Close
May 6, 2024 04:05PM
May 6, 2024 08:34AM
May 6, 2024 08:02AM
May 6, 2024 08:01AM
May 6, 2024 08:01AM
May 6, 2024 08:00AM
May 6, 2024 07:59AM Lyra Therapeutics (LYRA) says ENLIGHTEN 1 trial did not meet its primary endpoint
May 6, 2024 07:18AM
May 6, 2024 07:03AM
May 6, 2024 07:03AM
May 6, 2024 07:01AM
May 6, 2024 07:01AM
May 6, 2024 07:03AM
May 6, 2024 06:59AM Bristol-Myers Squibb (BMY) Announces FDA Acceptance of Application for Subcutaneous Nivolumab
May 6, 2024 06:59AM
May 6, 2024 06:08AM
May 6, 2024 06:01AM
May 6, 2024 06:00AM
May 6, 2024 05:37AM
May 3, 2024 01:15PM
May 3, 2024 08:02AM Gossamer Bio Inc. (GOSS) Announces Publication of TORREY Phase 2 Results
May 3, 2024 07:00AM
May 2, 2024 04:04PM
May 2, 2024 08:50AM
May 2, 2024 08:03AM
May 2, 2024 07:52AM
May 2, 2024 07:32AM
May 2, 2024 07:30AM Palatin Technologies (PTN) Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with Tirzepatide (GLP-1) for the Treatment of Obesity
May 2, 2024 07:00AM
May 2, 2024 06:04AM
May 1, 2024 09:01AM
May 1, 2024 08:46AM
May 1, 2024 08:36AM
May 1, 2024 08:32AM
May 1, 2024 08:31AM Aileron Therapeutics (ALRN) Reports Positive Data from Cohort 1 of the Phase 1b Trial of LTI-03
May 1, 2024 08:04AM
May 1, 2024 08:02AM
May 1, 2024 07:16AM
May 1, 2024 06:27AM
Apr 30, 2024 05:12PM
Apr 30, 2024 03:21PM
Apr 30, 2024 09:04AM ARS Pharmaceuticals (SPRY) Submits Response for neffy Marketing Authorization Application to EMA’s CHMP, Enters License Agreement with CSL Seqirus
Apr 30, 2024 08:33AM
Apr 30, 2024 08:31AM
Apr 30, 2024 08:07AM
Apr 30, 2024 08:06AM
Apr 30, 2024 08:03AM
Apr 30, 2024 08:01AM
Apr 30, 2024 07:31AM Virpax Pharmaceuticals (VRPX) Announces Results of Maximum Tolerated Dose Study for Probudur
Apr 30, 2024 07:07AM

66,983 total articles have been posted to this category.

Sign-up to StreetInsider.com Premium to see all today's market moving FDA reports.